Oral delivery of chitosan-bilirubin nanoparticles alleviates hepatic inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis
{{output}}
Metabolic dysfunction-associated steatohepatitis (MASH) is a severe chronic liver disease that often leads to complications, such as cirrhosis and hepatocellular carcinoma. Despite intensive research and development efforts, there are relatively few approved t... ...
